CatalystEU/UK

ASTRAZENECA SUBMITS NDA FOR SAVOLITINIB + TAGRISSO FOR NSCLC - SEEKINGALPHA

AstraZeneca submits NDA for savolitinib plus Tagrisso in NSCLC.

What changed

AstraZeneca submits NDA for savolitinib plus Tagrisso in NSCLC.

Why it matters

AstraZeneca submits NDA for savolitinib plus Tagrisso in NSCLC. — impact context not separately stored; see What changed.

Sources